Study on effect of anthracyclines on VEGF-C, VEGFR-3, ER and E-cadherin in serum of patients with breast cancer
- VernacularTitle:蒽环类药物对乳腺癌患者血清ER、VEGF-C、VEGFR-3及E-cadherin影响研究
- Author:
Daobao CHEN
;
Bo CHEN
;
Hongjian YANG
;
Xingfei YU
;
Weiliang FENG
- Publication Type:Journal Article
- Keywords:
Anthracyclines;
breast cancer;
ER;
VEGF-C;
VEGFR-3;
E-cadherin
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(6):137-139
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate effect of anthracyclines of VEGF-C, VEGFR-3, ER and E-cadherin in serum of patients with breast cancer.Methods 43 patients with breast cancer were selected and randomly divided into experimental group and control group, 40 cases in each group.According to the experimental program based on the treatment, serum VEGF-C, VEGFR-3 levels and breast tissue ER and E-cadherin were detected after the end of the treatment.Results Compared with the control group, VEGF-C, VEGFR-3 levels of the experiment group were lower( P<0.05),ER level was lower(P<0.05) and E-cadherin level was higher(P<0.05).Conclusion the ER, VEGFR-3 and VEGF-C levels in breast cancer patients can significantly decrease the E-cadherin level, and it has a guiding significance for clinical.
